Oncology Drug Advisory Committee

Results: 151



#Item
21[removed]Federal Register / Vol. 68, No[removed]Tuesday, November 18, [removed]Notices General Function of the Committee: To provide advice and

[removed]Federal Register / Vol. 68, No[removed]Tuesday, November 18, [removed]Notices General Function of the Committee: To provide advice and

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2003-11-18 06:37:42
22DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Pediatric Advisory Committee; Notice of Meeting AGENCY: ACTION:

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Pediatric Advisory Committee; Notice of Meeting AGENCY: ACTION:

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2007-10-11 08:11:54
23Treanda (bendamustine hydrochloride) Full Safety and Drug Utilization Review Provided in Background Materials  Pediatric Advisory Committee Meeting, September 23, 2014

Treanda (bendamustine hydrochloride) Full Safety and Drug Utilization Review Provided in Background Materials Pediatric Advisory Committee Meeting, September 23, 2014

Add to Reading List

Source URL: www.fda.gov

Language: English
24Federal Register / Vol. 72, No[removed]Thursday, August 16, [removed]Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2007P–0074]

Federal Register / Vol. 72, No[removed]Thursday, August 16, [removed]Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2007P–0074]

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2007-08-16 07:39:39
25Microsoft Word - AGENDA BRUDAC_Sept 18v2.doc

Microsoft Word - AGENDA BRUDAC_Sept 18v2.doc

Add to Reading List

Source URL: www.fda.gov

Language: English
26DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2007P[removed]Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2007P[removed]Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee; Notice of Meeting

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2007-08-14 16:44:15
27Federal Register / Vol. 79, No[removed]Thursday, October 9, [removed]Notices Mendrick at least 7 days in advance of the meeting. FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our W

Federal Register / Vol. 79, No[removed]Thursday, October 9, [removed]Notices Mendrick at least 7 days in advance of the meeting. FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our W

Add to Reading List

Source URL: www.fda.gov

Language: English
28FDA Briefing Document Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (ODAC) November 1, 2011  DISCLAIMER STATEMENT

FDA Briefing Document Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (ODAC) November 1, 2011 DISCLAIMER STATEMENT

Add to Reading List

Source URL: www.fda.gov

Language: English
29Pediatric Oncology Subcommittee of the Oncology Drugs Advisory Committee – Food and Drug Administration Open Session Meeting on Optimizing the Development of Oncology and Hematology Drugs for Pediatric Use MK-3475 Pedi

Pediatric Oncology Subcommittee of the Oncology Drugs Advisory Committee – Food and Drug Administration Open Session Meeting on Optimizing the Development of Oncology and Hematology Drugs for Pediatric Use MK-3475 Pedi

Add to Reading List

Source URL: www.fda.gov

Language: English
30FDA Briefing Document Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (ODAC) November 4, 2013  DISCLAIMER STATEMENT

FDA Briefing Document Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (ODAC) November 4, 2013 DISCLAIMER STATEMENT

Add to Reading List

Source URL: www.fda.gov

Language: English